Cancer & SURVIVEiT News
Category Filter:
A Look Back At 2020 FDA Approvals By Cancer Type
Over the year, SURVIVEiT® has updated the Newsroom and social media with FDA approvals and notifications relevant to oncology. In case you missed some of the updates, here is a comprehensive…
How CRISPR Is Changing Cancer Research and Treatment
How CRISPR Is Changing Cancer Research and Treatment The new tool has taken the research world by storm, markedly shifting the line between possible and impossible. As soon as CRISPR…
Cancer Immunotherapy Tied to Severe COVID-19 Outcomes
Cancer Immunotherapy Tied to Severe COVID-19 Outcomes Cancer patients receiving immunotherapy were at increased risk for severe outcomes from COVID-19, according to retrospective findings from Memorial Sloan Kettering Cancer Center…
FDA approves pembrolizumab for adults and children with TMB-H solid tumors
FDA approves pembrolizumab for adults and children with TMB-H solid tumors On June 16, 2020, the Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA, Merck & Co., Inc.)…
FDA approves new dosing regimen for pembrolizumab
FDA approves new dosing regimen for pembrolizumab On April 28, 2020, the Food and Drug Administration granted accelerated approval to a new dosing regimen of 400 mg every six weeks…
FDA approves new dosing regimen for pembrolizumab
FDA approves new dosing regimen for pembrolizumab On April 28, 2020, the Food and Drug Administration granted accelerated approval to a new dosing regimen of 400 mg every six weeks…
Bristol Myers Squibb Expands Patient Support Programs to Help Newly Uninsured Patients in the U.S.
Bristol Myers Squibb Expands Patient Support Programs to Help Newly Uninsured Patients in the U.S. PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced an expansion of its existing patient…
Relax Comorbidity Criteria in Cancer Trials?
Relax Comorbidity Criteria in Cancer Trials? More than 6,000 additional patients could be enrolled each year by Ian Ingram, Deputy Managing Editor, MedPage Today January 14, 2019 As efforts are being made to…
FDA approves Vitrakvi based on shared mutation rather than a specific type of tumor
FDA approves ‘precision medicine’ drug for different cancers with same mutation By Laurie McGinley Laurie McGinley November 26 The Food and Drug Administration on Monday approved a drug for a wide…